Difference between revisions of "Temozolomide"

Jump to navigation Jump to search
4 bytes added ,  11:22, 23 March 2017
wikify
(wikify)
Line 1: Line 1:
'''Temozolomide''' is an oral alkylating agent used to treat [[glioma]] - especially [[glioblastoma]].<ref>{{Cite journal  | last1 = Stupp | first1 = R. | last2 = Hegi | first2 = ME. | last3 = Mason | first3 = WP. | last4 = van den Bent | first4 = MJ. | last5 = Taphoorn | first5 = MJ. | last6 = Janzer | first6 = RC. | last7 = Ludwin | first7 = SK. | last8 = Allgeier | first8 = A. | last9 = Fisher | first9 = B. | title = Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. | journal = Lancet Oncol | volume = 10 | issue = 5 | pages = 459-66 | month = May | year = 2009 | doi = 10.1016/S1470-2045(09)70025-7 | PMID = 19269895 }}</ref>
'''Temozolomide''' is an oral alkylating agent used to treat [[glioma]] - especially [[glioblastoma]].<ref>{{Cite journal  | last1 = Stupp | first1 = R. | last2 = Hegi | first2 = ME. | last3 = Mason | first3 = WP. | last4 = van den Bent | first4 = MJ. | last5 = Taphoorn | first5 = MJ. | last6 = Janzer | first6 = RC. | last7 = Ludwin | first7 = SK. | last8 = Allgeier | first8 = A. | last9 = Fisher | first9 = B. | title = Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. | journal = Lancet Oncol | volume = 10 | issue = 5 | pages = 459-66 | month = May | year = 2009 | doi = 10.1016/S1470-2045(09)70025-7 | PMID = 19269895 }}</ref>
The therapeutic effect is dependent on the  O-6-methylguanine-DNA methyltransferase (MGMT) gene promotor methylation.
The therapeutic effect is dependent on the  [[O-6-methylguanine-DNA methyltransferase]] (MGMT) gene promotor methylation.
<!--- ==See also==
<!--- ==See also==
*[[Dacarbazine]]. --->
*[[Dacarbazine]]. --->
Account-creators
1,040

edits

Navigation menu